GetTopicDetailResponse(id=73d4425e0cb, topicName=復(fù)發(fā)或難治性多發(fā)性骨髓瘤, introduction=復(fù)發(fā)或難治性多發(fā)性骨髓瘤, content=null, image=null, comments=0, allHits=1093, url=https://h5.medsci.cn/topic?id=42570, type=1, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=96224, tagList=[TagDto(tagId=96224, tagName=復(fù)發(fā)或難治性多發(fā)性骨髓瘤)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2250654, encodeId=00992250654da, content=<a href='/topic/show?id=73d4425e0cb' target=_blank style='color:#2F92EE;'>#復(fù)發(fā)或難治性多發(fā)性骨髓瘤#</a> <a href='/topic/show?id=6b67112e51a8' target=_blank style='color:#2F92EE;'>#特立妥單抗#</a> <a href='/topic/show?id=7b731239e1c3' target=_blank style='color:#2F92EE;'>#塔奎妥單抗#</a>, objectTitle=NEJM | 復(fù)發(fā)或難治性多發(fā)性骨髓瘤治療新突破：塔奎妥單抗聯(lián)合特立妥單抗顯示出強大的抗腫瘤活性, objectType=article, longId=862115, objectId=ad82862115b4, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20250120/1737355951876_8538692.png, objectUrl=/article/show_article.do?id=ad82862115b4, replyNumber=0, likeNumber=39, createdTime=2025-02-05, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陜西省, moduleDTOList=[ModuleDTO(moduleId=ad82862115b4, moduleTitle=NEJM | 復(fù)發(fā)或難治性多發(fā)性骨髓瘤治療新突破：塔奎妥單抗聯(lián)合特立妥單抗顯示出強大的抗腫瘤活性, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=ad82862115b4)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2204276, encodeId=407b22042e673, content=<a href='/topic/show?id=f336e29134' target=_blank style='color:#2F92EE;'>#FDA#</a> <a href='/topic/show?id=73d4425e0cb' target=_blank style='color:#2F92EE;'>#復(fù)發(fā)或難治性多發(fā)性骨髓瘤#</a> <a href='/topic/show?id=85fa10446166' target=_blank style='color:#2F92EE;'>#西達基奧侖賽#</a>, objectTitle=CLIN CANCER RES | FDA批準(zhǔn)摘要：西達基奧侖賽治療復(fù)發(fā)或難治性多發(fā)性骨髓瘤, objectType=article, longId=825535, objectId=5b99825535a3, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240512/1715493300929_6145188.png, objectUrl=/article/show_article.do?id=5b99825535a3, replyNumber=0, likeNumber=123, createdTime=2024-05-12, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=5b99825535a3, moduleTitle=CLIN CANCER RES | FDA批準(zhǔn)摘要：西達基奧侖賽治療復(fù)發(fā)或難治性多發(fā)性骨髓瘤, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=5b99825535a3)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2199559, encodeId=4bb8219955910, content=<a href='/topic/show?id=1f188e230c5' target=_blank style='color:#2F92EE;'>#薈萃分析#</a> <a href='/topic/show?id=2ad83e51258' target=_blank style='color:#2F92EE;'>#雙特異性抗體#</a> <a href='/topic/show?id=bcbd384814' target=_blank style='color:#2F92EE;'>#B細胞成熟抗原#</a> <a href='/topic/show?id=73d4425e0cb' target=_blank style='color:#2F92EE;'>#復(fù)發(fā)或難治性多發(fā)性骨髓瘤#</a>, objectTitle=?Front Immunol：雙特異性抗體治療復(fù)發(fā)或難治性多發(fā)性骨髓瘤的療效和安全性, objectType=article, longId=822495, objectId=86848224950f, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20221201/1669967708187_4754896.jpeg, objectUrl=/article/show_article.do?id=86848224950f, replyNumber=0, likeNumber=155, createdTime=2024-04-21, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=86848224950f, moduleTitle=?Front Immunol：雙特異性抗體治療復(fù)發(fā)或難治性多發(fā)性骨髓瘤的療效和安全性, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=86848224950f)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2193705, encodeId=8ae92193e058d, content=<a href='/topic/show?id=73d4425e0cb' target=_blank style='color:#2F92EE;'>#復(fù)發(fā)或難治性多發(fā)性骨髓瘤#</a> <a href='/topic/show?id=141d40627a' target=_blank style='color:#2F92EE;'>#CAR-T#</a> <a href='/topic/show?id=833732e80d' target=_blank style='color:#2F92EE;'>#BCMA#</a>, objectTitle=EBMT摘要: RRMM中不同BCMA CAR-T的有效性間接比較, objectType=article, longId=817278, objectId=528b81e278a3, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/medical-researcher-looking-through-the-microscope-64JFWLH.jpg, objectUrl=/article/show_article.do?id=528b81e278a3, replyNumber=0, likeNumber=101, createdTime=2024-03-17, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=528b81e278a3, moduleTitle=EBMT摘要: RRMM中不同BCMA CAR-T的有效性間接比較, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=528b81e278a3)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯話題小助手
2020-05-29
